ARTEMIS CYSTITIS LIMITED

🏛️Establishedactive
12865469 · ltd · incorporated 2020-09-08
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
🔒Estimated value
Upgrade to see
Turnover
year to Mar 2025
Net worth
book net assets
Opportunity
71/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Specialist medical practice activities
Sector: Human health & social work
Investor take
Pursue
Strong opportunity: active trading company with strong profile and bankable structure.

Opportunity 71/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (65/100).

Data confidence

Overall: medium (78/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
4 officers (2 active, 4 linked, 4 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
Network not yet resolved
30
Filing history
23 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
🔒Estimated company valuation

Sector-multiple EBITDA, turnover, and NAV-proxy valuation range with confidence tier — derived from extracted iXBRL financials.

Available from the Pro tier upwards.

See pricing →
Opportunity Score
71/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
65
Adequate — check latest filings for context.
Acquirability
50
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
Current Assets
Current Liabilities
£0£0£0£0£0£0Mar 2024Mar 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102
Metric2025-03-312024-03-31
Average employees300300

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
1
filing
  • 1 officers
Last 180 days
1
filing
  • 1 officers
Counts from Companies House filing history.
Corporate timeline (25 events)Click to expand
  1. 2026-06-01
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  2. 2025-11-17
    📄
    capital-return-purchase-own-shares
    capital · SH03
  3. 2025-10-07
    📄
    capital-cancellation-shares
    capital · SH06
  4. 2025-09-05
    DALEY-PEART, Martel Elizabeth resigned
    director
  5. 2025-08-22
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  6. 2024-09-26
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  7. 2024-06-17
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  8. 2023-12-11
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  9. 2023-09-15
    📄
    change-person-director-company-with-change-date
    officers · CH01
  10. 2023-09-15
    📄
    change-person-director-company-with-change-date
    officers · CH01
  11. 2022-10-31
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  12. 2022-05-25
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  13. 2022-05-23
    📄
    change-account-reference-date-company-current-shortened
    accounts · AA01
  14. 2022-05-23
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  15. 2022-02-19
    MALONE-LEE, James, Professor resigned
    director
  16. 2022-01-13
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  17. 2022-01-12
    HARVEY, Edward David Stephen, Dr appointed
    director
  18. 2022-01-12
    MALONE-LEE, Matthew Joseph, Dr appointed
    director
  19. 2022-01-12
    DALEY-PEART, Martel Elizabeth appointed
    director
  20. 2022-01-12
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  21. 2022-01-12
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  22. 2021-01-25
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  23. 2020-09-08
    🏢
    Company incorporated
    As ARTEMIS CYSTITIS LIMITED
  24. 2020-09-08
    MALONE-LEE, James, Professor appointed
    director
  25. 2020-09-08
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

58/100
Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS
  • +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.

Succession & seller-readiness

36/100
Weak signal

Limited succession signal. Not a near-term off-market candidate.

SIGNALS
  • secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

1 active beneficial owner
NameSharesVoting rightsNature of controlNotified
Professor James Malone-Lee
Individual · British · DOB 09/1951 · age 75
5075%
50–75%board control50-75% shares · 50-75% voting · board control08/09/2020

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Healthcare & medical · EC postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
A TIME TO HEAL LTD
13316044 · est 2021 · no financials extracted
5y
APRP GROUP LTD
16602418 · est 2025 · no financials extracted
ARICARE HEALTH LTD
16264468 · est 2025 · no financials extracted
1y
ARJUNA HEALTHCARE LIMITED
15152618 · est 2023 · no financials extracted
2y
ARKMED LTD
14164311 · est 2022 · no financials extracted
3y
ARTHREGEN LTD
15553043 · est 2024 · no financials extracted
2y
ARTHRITIS LIFESTYLE LTD
16642643 · est 2025 · no financials extracted
ARTHRITIS UK
00490500 · est 1951 · no financials extracted
75y
ARYANA MEDICAL LIMITED
16676276 · est 2025 · no financials extracted
ASC CBT THERAPY LTD
16255626 · est 2025 · no financials extracted
1y
ASCEND ADVANCED PRACTICE LTD
16893776 · est 2025 · no financials extracted
ASPIRE CHILDREN SERVICES LIMITED
15230091 · est 2023 · no financials extracted
2y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2020-09-08
Jurisdictionengland-wales
Primary SIC86220 — Specialist medical practice activities

Registered office

Kalamu House
11 Coldbath Square
London
EC1R 5HL
England

Filing status

Accounts
Next due: 2026-12-31
Last made up to: 2025-03-31
Confirmation statement
Next due: 2026-09-03
Last: 2025-08-20

Officers (2 active · 2 resigned)

HARVEY, Edward David Stephen, Dr
director · ~42y · appointed 2022-01-12
View their other companies + combined net worth →
Active
MALONE-LEE, Matthew Joseph, Dr
director · ~50y · appointed 2022-01-12
View their other companies + combined net worth →
Active
DALEY-PEART, Martel Elizabeth
director · ~39y · appointed 2022-01-12 · resigned 2025-09-05
Resigned
MALONE-LEE, James, Professor
director · ~75y · appointed 2020-09-08 · resigned 2022-02-19
Resigned

Click a director name to see their full track record across all companies.

Recent filings (23 total)

termination-director-company-with-name-termination-date
officers · TM01
2026-06-01
capital-return-purchase-own-shares
capital · SH03
2025-11-17
capital-cancellation-shares
capital · SH06
2025-10-07
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-08-22
confirmation-statement-with-updates
confirmation-statement · CS01
2025-08-20
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-10-11
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-09-26
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2024-06-17
accounts-with-accounts-type-total-exemption-full
accounts · AA
2023-12-11
confirmation-statement-with-updates
confirmation-statement · CS01
2023-09-21
change-person-director-company-with-change-date
officers · CH01
2023-09-15
change-person-director-company-with-change-date
officers · CH01
2023-09-15
accounts-with-accounts-type-total-exemption-full
accounts · AA
2022-10-31
confirmation-statement-with-updates
confirmation-statement · CS01
2022-10-11
accounts-with-accounts-type-total-exemption-full
accounts · AA
2022-05-25